Jeff Aron­in's start­up in­cu­ba­tor scoops ex-Alk­er­mes ex­ec Jim Robin­son for new pres­i­dent/COO role

Af­ter a stint at Alk­er­mes $ALKS that took him to Boston area for a lit­tle over a year, Jim Robin­son is mov­ing home.

Re­port­ing at Paragon Bio­sciences’ Chica­go of­fice to­day, Robin­son will keep the same ti­tle: pres­i­dent and chief op­er­at­ing of­fi­cer. But in­stead of over­see­ing one en­ti­ty, he will run a host of func­tion­al ser­vices to sup­port Paragon’s six and count­ing port­fo­lio com­pa­nies.

Serv­ing on Paragon’s ad­vi­so­ry board for the past two years has giv­en him “a bird’s eye view” not on­ly on its mis­sion and busi­ness mod­el, but al­so the team that chair­man and CEO Jeff Aronin has as­sem­bled. Over the last 18 months, they have pooled close to $500 mil­lion in in­vest­ment for the biotech star­tups they launched, got up and run­ning, then set sail as in­de­pen­dent­ly run op­er­a­tions.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.